More on TARA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders

Upcoming Events

- Earnings (10/29/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Protara Therapeutics (NQ:TARA)
Delayed: 2.32 -0.08 (3.33%)
Prev. Close $2.40  
Open$2.38 
52 Wk High$ 
52 Wk Low$ 
Day High$2.47 
Day Low$2.32 
P/E N/A  
EPS$ 
Volume1,165,281 


Oct 15, 2026 08:00 AM Protara completes enrollment in THRIVE-3 Phase 2b trial
Oct 15, 2026 08:00 AM Protara Therapeutics Completes Enrollment of the Phase 2b Open-Label Dose Confirmation Phase of the THRIVE-3 Registrational Trial of IV Choline Chloride in Patients on Parenteral Support
Oct 15, 2026 07:54 AM Protara Therapeutics (TARA) Reiterated at Overweight by Cantor Fitzgerald After Management Meet
Aug 13, 2026 12:47 PM Form SCHEDULE 13G/A Protara Therapeutics, Filed by: Janus Henderson Group Ltd.
Aug 11, 2026 04:16 PM Form S-8 Protara Therapeutics,
Aug 11, 2026 09:36 AM Protara Therapeutics, Inc. (TARA) Misses Q2 EPS by 2c
Aug 11, 2026 08:11 AM Form 10-Q Protara Therapeutics, For: Jun 30
Aug 11, 2026 08:06 AM Form 8-K Protara Therapeutics, For: Aug 11
Aug 11, 2026 08:00 AM Protara Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update
Jul 7, 2026 06:43 PM Form SCHEDULE 13G/A Protara Therapeutics, Filed by: MILLENNIUM MANAGEMENT LLC
View All Articles

Entities mentioned with TARA

View All Entities